FDA Inspection
ChemPacific CorporationChemPacific Corporation – FDA Inspection, Apr 7, 2026
Record Details
This FDA Inspection record concerns ChemPacific Corporation, with an inspection on April 7, 2026, issued by the Baltimore District Office, covering human drugs.
View Company Profile
ID · 11728183-b324-422d-90e8-e0d06526d019
Inspection Facts
- Inspection number
- 1315036
- FDA center
- Human Drugs
Other FDA inspections of ChemPacific Corporation
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 15, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 18, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 9, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 14, 2010 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ChemPacific Corporation
- FDA Inspection 1231373 - 2024-02-15
- FDA Inspection 981629 - 2016-08-18
- FDA Inspection 826282 - 2013-04-09
- FDA Inspection 753744 - 2011-11-18
- FDA Inspection 694683 - 2010-10-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.